The Martin-Hopkins equation to assess low-density lipoprotein (LDL) cholesterol levels in blood samples has been used by ...

The European Society of Cardiology has released a 2025 update to its 2019 dyslipidemia guidelines, incorporating new evidence that has shaped lipid-lowering strategies in recent years. The revisions ...

Adding ezetimibe to moderate-intensity statin therapy reduces the risk of major cardiovascular events in post-ACS patients with a range of baseline LDL-cholesterol levels, including those with values ...

The risk of myocardial infarction in patients with and without atherosclerosis is best predicted by the number of apolipoprotein B (apoB)-containing lipoproteins, and this risk is independent from the ...

Abbott is a global healthcare company that creates life-changing products—in diagnostics, medical devices, nutrition and branded generic pharmaceuticals—that help people and their families lead ...

Evolocumab's indication now includes adults at risk of cardiovascular events due to uncontrolled LDL-C, even without a formal diagnosis. The therapy is approved for use in patients with high LDL-C ...

Lipid metabolism encompasses the synthesis, transport and utilisation of fats and cholesterol within the body, processes that malignant tissues reprogramme to support rapid proliferation. Cancer cells ...